Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2025-12-24 @ 7:58 PM
NCT ID:
NCT00858104
Eligibility Criteria:
Inclusion Criteria:
* The presence of a single nodule or dominating nodule;
* A solid or mixed echo-structure with less than 20% fluid volume;
* A lesion volume between 5 and 18 ml (greatest diameter \> 3.0 cm and \<= 4 cm);
* Thyroid hormone and TSH serum levels within the normalcy value;
* 2 cytologically negative examinations for suspected neoplasia (British Thyroid Association, Second class THY)within the last six months;
* Calcitonin values within the normalacy value;
* Anticoagulant treatment suspension and antiaggregation treatment suspended for at least 72 hours.
Exclusion Criteria:
* Hyperfunctioning lesion (99mTc scintigraph);
* Autoimmune thyreopathy or elevation of autoantibodies;
* Active anticoagulant treatment or antiaggregation treatment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00858104
Study Brief:
Protocol Section:
NCT00858104